Underlying Wrigley Field growthof

Underlying discloses about wrigley field growthof 2.3 ballpark field devises percent over prior year excluded a $6.2 million reduction fromforeign exchange. Sales of new products achieved strong growth for thequarter, while constraints on hospital capital spending had a continuedimpact on overall sales growth."We expect new product introductions to drive higher Critical Care growthrates in the second half of the year. This improvement was dueprimarily to product mix and the favorable impact of foreign exchangehedge agreements.Selling, general and administrative expenses were $128.5 million for thequarter, or 38.3 percent of sales, compared to $126.5 million in the prioryear. Options are notgenerally exercisable during the first 12 months after the date of grant. AtJune 30, 2009, 12.3 million common shares remained authorized for futureissuances under this plan. The total number of options outstanding at June 30,2009, including conventional and performance-accelerated options, was 10.5million and 3.1 million, respectively.The following table provides the activity of stock option awards in 2009.

CommitmentsAs at June 30, 2009, the Company had commitments to acquire railroad ties,rail, freight cars, locomotives, and other equipment and services, as well asoutstanding information technology service contracts and licenses, at anaggregate cost of $797 million ($1,006 million at December 31, 2008) address for wrigley field . TheCompany also has agreements with fuel suppliers to purchase approximately 95%of the estimated remaining 2009 volume, 64% of its anticipated 2010 volume,and 28% of its anticipated volumes for each of the years from 2011 through2013, at market prices prevailing on the date of the purchase.B baseball . For all other legal actions, the Companymaintains, and regularly updates on a case-by-case basis, provisions for suchitems when the expected loss is both probable and can be reasonably estimatedbased on currently available information.United StatesEmployee work-related injuries, including occupational disease claims, arecompensated according to the provisions of the Federal Employers' LiabilityAct (FELA), which requires either the finding of fault through the U.S baseball tickets . Second quarter diluted earnings per share increased 20.9percent over last year cellular field seating chart . Excluding special items, diluted earnings pershare grew 19.7 percent.Second quarter net sales increased 2.4 percent to $335.5 million.Underlying(1) sales growth was 9.8 percent, which primarily excludes an$18.4 million negative impact from foreign exchange and the divestiture ofthe LifeStent product line."Share gains across all regions drove double digit heart valve therapygrowth, resulting in strong second quarter results," said Michael A.Mussallem, Edwards Lifesciences' chairman and CEO."With the continued adoption of our transcatheter heart valves, we remainconfident that we will reach more than $100 million in sales outside ofthe U.S this year. patients as we approachcompletion of our PARTNER trial enrollment."Sales ResultsFor the second quarter, the company reported Heart Valve Therapy sales of$182.1 million. Underlying growth of 16.7 percent over the prior yearexcluded the impact of $10.2 million from foreign exchange and $4.1million related to the re-launch of previously retrieved mitral valverepair products."Our Heart Valve Therapy sales growth was driven primarily by our EdwardsSAPIEN transcatheter valve, which grew to $26.5 million in the quarter.Based on our current performance and foreign exchange rates, we areincreasing the midpoint of our prior Heart Valve Therapy sales guidancefor 2009 by $25 million to $690 to $710 million," said Mussallem.Critical Care sales were $113.0 million for the quarter.

Additionally, we continue to make progress towardsbringing this exciting technology to U.S address of wrigley field . Excluding special itemsdetailed in the reconciliation table below, second quarter 2009 netincome was $46.4 million, or $0.79 per diluted share, compared to netincome of $39.0 million, or $0.66 per diluted share, for the same periodlast year citifield stadium . Certain factors that couldcause actual results to differ materially from those contained in theforward-looking statements, are included in the Company's periodic reportsfiled with the Securities and Exchange Commission ("SEC") city of palms park . Copies areavailable on the SEC's website, The Company disclaims anyobligation to update or revise any forward-looking statements based on theoccurrence of future events, the receipt or new information, or otherwise.SOURCEAmerican Capital Agency Corp.Investors, +1-301-968-9300 ballpark field .

IRVINE, CA, Jul 20 (MARKET WIRE) -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in productsand technologies to treat advanced cardiovascular disease, today reportednet income for the quarter ended June 30, 2009 of $47.5 million, or $0.81per diluted share, compared to net income of $39.7 million, or $0.67 perdiluted share, for the same period in 2008 address to wrigley field . Forward-looking statements involve risks anduncertainties in predicting future results and conditions baseball . Actual resultscould differ materially from those projected in these forward-lookingstatements due to a variety of factors, including, without limitation, changesin interest rates, changes in the yield curve, changes in prepayment rates,the availability and terms of financing, changes in the market value of ourassets, general economic conditions, market conditions, conditions in themarket for agency securities, and legislative and regulatory changes thatcould adversely affect the business of the Company baseball tickets . Forward-lookingstatements are based on estimates, projections, beliefs and assumptions ofmanagement of the Company at the time of such statements and are notguarantees of future performance .